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CHAPTER 1: GENERAL INTRODUCTION 
Thesis Organization 
 This thesis is presented as a manuscript prepared for the submission to the 
Journal of Dairy Science. It is prepared from research to fulfill the requirements for 
the Master of Science degree. This paper is complete by itself; it contains an abstract, 
introduction, materials and methods, results, discussion, conclusion, and references. 
The paper is entitled “Effects of glucagon, glycerol, and glucagon plus glycerol on 
gluconeogenesis, lipogenesis, and lipolysis in periparturient Holstein cows” and 
indicates the potential use of glucagon as a preventive agent of the fatty liver disease 
in transition dairy cows. The paper is preceded by a general literature review and 
followed by general conclusions, discussion, and recommendations for further future 
research. Finally, it is concluded by a list of references. 
Introduction 
With a prevalence up to 54% of a dairy herd (Jorritsma et al., 2001) and a 
morbidity and mortality up to 90% and 25%, respectively (Raoofi et al., 2001), fatty 
liver (hepatic lipidosis) causes a major economic loss for  U.S dairy farmers 
(Littledike et al., 1981). Fatty liver is a metabolic disorder and develops during early 
lactation of dairy cows. Fatty liver disease affects the health status, productivity, and 
reproductive performance (Gerloffe and Herdt, 1984; Jorritsma et al., 2001). Cows 
with fatty liver also can develop many other side conditions such as ketosis, milk 
fever, udder edema, displaced abomasum, retained placenta, metritis, and mastitis 
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(Morrow, 1976; Drackley, 1999; Katoh, 2002; van Winden et al., 2003). Bobe et al. 
(2004) extensively reviewed the epidemiology, pathology, and etiology of fatty liver 
in dairy cattle. The molecular basis of the development of the disease was reviewed in 
detail (Nafikov et al., 2006).  
This review will focus on the molecular and cellular changes that affect the 
three basic metabolic pathways involved in the development of fatty liver disease: 
gluconeogenesis, lipogenesis, and lipolysis. Then, it summarizes what is known about 
the involvement of tumor necrosis factor-alpha (TNF-α) in the development of fatty 
liver and in the control of the different metabolic pathways. Finally, the review will 
focus on the metabolic and cellular changes caused by glucagon in alleviating and 
preventing fatty liver development. 
Gluconeogenesis 
 Suppression of gluconeogenesis is one of the major metabolic changes that 
occur during fatty liver condition in dairy cattle (Bobe et al., 2004). Activities of 
several hepatic enzymes were lower in fatty liver cows compared with control cows 
during the prepartal period (Murondoti et al., 2004; Rukkwamsuk et al., 1999a; 
Graber et al., 2010). Both phosphoenolpyruvate carboxykinase (PEPCK) and 
propionyl-CoA carboxylase (PCC) activities remain low in fatty liver cows after 
parturition (Rukkwamsuk et al., 1999a; Murondoti et al., 2004). As for pyruvate 
carboxylase (PC), its activity increased after calving for both control and fatty liver 
cows (Murondoti et al., 2004). Glucose 6-phosphatase (G6Pase) activity, on the other 
hand, showed a tendency to be higher in fatty liver cows than in control cows 
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(Murondoti et al., 2004). The authors suggested that rapid breakdown of stored liver 
glycogen of fatty liver cow is the reason for such high activity of G6Pase during high 
energy demanding postpartal period. Fructose-1,6-bisphosphatase (FBPase) activity 
showed no significant difference between controls and fatty liver cows (Murondoti et 
al., 2004). Others, however, have shown a tendency in FBPase activity to increase in 
the postpartal period (Rukkwamsuk et al., 1999a). 
 During the development of the fatty liver condition, the different hormones 
and nutrients that control gluconeogenesis including insulin, glucagon, TNF-α, 
glucose, and fatty acids; however, glucagon and TNF-α will be discussed in later 
section of this literature review. 
Insulin. Because of its direct suppressant effect on PEPCK gene transcription as 
shown in H4IIE hepatoma cells (Granner et al., 1983; Beale et al., 1986), high insulin 
concentrations during the prepartal period could be a major player in the suppression 
of gluconeogenesis in postpartal fatty liver cows. Velez and Donkin (2005) showed 
that PEPCK mRNA concentrations increased significantly in the livers of cows 
experiencing low insulin concentrations as a result of feed restriction. The same study, 
however, showed no effect of feed restriction on PC mRNA concentrations. The 
molecular mechanism by which insulin suppresses PEPCK activity is better 
understood in nonruminant than ruminant animals. In rats, insulin suppresses PEPCK 
transcription through an insulin response element (IRE), which is a part of the 
glucocorticoid response unit (GRU) in the third region of the PEPCK promoter of the 
H4IIE hepatoma cells (O'Brien et al., 1990; Chakravarty and Hanson, 2007; Yabaluri 
and Bashyam, 2010). Insulin down-regulates PC expression in livers of diabetic rats 
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(Weinberg and Utler, 1980). Although the mechanism is not clearly understood, there 
is evidence that insulin promotes PC gene expression through IRE in the proximal 
promoter of the gene (Jitrapakdee et al., 1997). Insulin is also a potent suppressor of 
G6Pase; it lowers both the G6Pase mRNA concentrations and activity in rat livers 
(Argaud et al., 1996; Massillon et al., 1996). 
Glucose. Another potential suppressant of gluconeogenic enzymes is the end product 
of the process itself, i.e., glucose. Glucose expresses an inhibitory effect on the 
transcription of PEPCK gene in rat hepatocytes through the first 490-bp region of the 
PEPCK gene promoter (Cournarie et al., 1999). This effect, however, can only take 
place if glucose is phosphorylated by glucokinase (Cournarie et al., 1999).  
 An insulin–independent effect of glucose on gluconeogenesis also is exerted 
through glucose activation of G6Pase gene expression in rat liver (Lange et al., 1994) 
(Massillon et al., 1996); in this case too, glucose phosphorylation by glucokinase is a 
condition for this effect to take place (Arguad et al., 1997). 
Fatty Acids. Accumulating lipids in liver could be another factor contributing to the 
suppression of gluconeogenesis during the fatty liver condition in dairy cows 
(Cadórniga-Valiño et al., 1997). Aiello and Armentano (1988) provided evidence that 
rates of propionic acid conversion to glucose in goat hepatocytes increased in the 
presence of oleic acid compared with control of no oleic acid. The same study, 
however, showed that oleic acid has no effect on gluconeogenesis in calf hepatocytes. 
In another study, oleic acid previously or concurrently incubated with calf 
hepatocytes decreased propionic acid conversion to glucose by 24% compared with 
that in controls with no fatty acid treatment (Cadórniga-Valiño et al., 1997). A third 
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study showed that concurrent exposure of bovine hepatocytes to oleic acid has no 
effect on rates of gluconeogenesis from propionic acid (Strang et al., 1998). Finally, 
in a more recent study, Mashek et al. (2002) found that bovine hepatocytes treated 
with oleic acid have higher gluconeogenesis rates from propionic acid. On the basis 
of previous data, the effect of oleic acid on conversion of propionic acid to glucose 
seems relatively weak and is subject to different experimental conditions (Mashek et 
al., 2002). The effect of fatty acids other than long-chain monosaturated fatty acids on 
gluconeogenesis were studied too. Polyunsaturated fatty acids (PUFA) such as 
arachidonic acid (C22:6) inhibited propionic acid conversion to glucose or to cellular 
glycogen in bovine hepatocytes (Mashek and Grummer, 2004). The same group 
found that different conjugated linoleic acid (CLA) isomers have no effect on rates of 
gluconeogenesis from propionic acid in bovine hepatocytes (Mashek and Grummer, 
2004). In nonruminants, rats fed high fat diets showed more FBPase protein 
concentrations and greater rates of alanine conversion to glucose in liver (Song et al., 
2001). Authors suggested that elevated hepatic lipid perooxidation rates activated the 
nuclear factor kappa B (NFκB), which is a regulator of hepatic FBPase gene 
expression (Fong et al., 2000). As for PEPCK, oleic acid was found to be a potent 
stimulator of PEPCK gene expression in rat adipocytes (Antras-Ferry et al., 1995). 
Free fatty acid stimulating effect on PEPCK is mediated by p38 mitogen-activated 
protein kinase (MAPK) (Collins et al., 2006). G6Pase gene expression also is up-
regulated by fatty acids (Massillon et al., 1997; Charelain et al., 1998). In vitro, PUFA 
suppressed G6Pase transcription in HepG2 hepatoma cells by inhibiting the 
hepatocyte nuclear factor 4-alpha (HNF4-α), which is an activator of the promoter for 
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the G6Pase gene (Rajas et al., 2002). Short-chain fatty acids induced G6Pase gene 
expression in H4IIE hepatoma cells by activating HNF4-α (Massillon et al., 2003). 
On the other hand, NEFA seem to regulate PC mRNA expression through specific 
activation of PC promoter 1 (White et al. 2010). 
Lipogenesis 
 Although esterification of plasma nonsterified fatty acids (NEFA) contributes 
up to 60% of the triacylglycerols (TAG) accumulating in livers of human patients 
with nonalcoholic fatty liver disease (NAFLD), de novo lipogenesis, on the other 
hand, is not unimportant; it accounts for about 26% of the TAG in  livers of patients 
with NAFLD (Donnelly et al., 2005). In normal healthy human livers, the 
contribution of de novo lipogenesis to TAG synthesis did not exceed 5% (Timlin et al., 
2005); however, patients with both insulin resistance conditions and NAFLD showed 
a five-fold increase in lipogenesis compared with that of normal subjects. This 
comparison indicates that greater rates of lipogenesis contribute to the fatty liver 
condition (Schwarz et al., 2003). As for adipose tissue, the other major anatomical 
site of lipogenesis, despite its active lipogenesis, its contribution to TAG storage in 
liver is relatively minor compared with hepatic de novo lipogenesis (Diraison et al., 
2003b). Hepatic lipogenesis significantly increases with high insulin plasma 
concentrations associated with high carbohydrate diets (Diraison et al., 2003a). 
 In ruminants, lipogenesis mostly takes place in adipose tissue rather than in 
liver; both liver and adipose tissues are significant sites of lipogenesis in 
nonruminants (Bauman, 1976). However, de novo lipogenesis in adipose contributes 
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only to about 30-35% of adipose deposition in ruminants (Vernon, 1983); the 
reminder of stored TAG is derived from the diet. The contribution of de novo 
lipogenesis to fatty liver development in ruminants has not yet been studied. Recently, 
it was shown that the expression of genes coding for lipogeneic enzymes decreases in 
adipose tissue between 30 d prepartum and 14 d in milk in first-lactation dairy cows 
(Sumner-Thomson et al., 2011). The rate of fatty acid esterification in adipose tissue 
of overfed cows significantly increases before parturition (Rukkwamsuk et al., 1999b). 
In addition, unrestricted feeding increases hepatic esterification rates of fatty acids by 
raising glycerolphosphate acyltransferase (GPAT) activity in the prepartal period of 
dairy cows (van den Top et al., 1996); lipogenesis in adipose tissue, however, is 
suppressed significantly after calving (van den Top et al., 1996; Rukkwamsuk et al., 
1999b; Murondoti et al., 2004). Integration of the activation of lipogenesis by high 
carbohydrate diets and high insulin concentrations in nonruminants (Tamura and 
Shimomura, 2005) in addition to the increased esterification of fatty acids in adipose 
tissue and livers of ruminants (van den Top et al., 1996; Rukkwamsuk et al., 1999b) 
could shed some light on the contribution of de novo lipogenesis in adipose tissue to 
development of fatty liver in cattle. 
 Lipogenesis in adipose tissue is controlled by different nutritional and 
hormonal factors; the next four parts will cover regulation by insulin, leptin, glucose, 
and PUFA. Effect of glucagon and TNF-α on lipogenesis will be discussed under 
later separate topics. 
Insulin. Insulin stimulates lipogenesis in liver and adipose tissue of both ruminants 
and nonruminants (Vernon, 1983). High energy, unrestricted diets during the prepartal 
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period of dairy cows increases plasma insulin concentrations, and, as a consequence, 
lipogenesis rates increase during that particular period (Rukkwamsuk et al., 1999b). 
Insulin activates lipogenesis by two different mechanisms that explain short-term and 
long-term effects (Kresten, 2001). Acetyl-CoA carboxylase (ACC), a key enzyme in 
lipogenesis pathway, is activated indirectly by insulin (Naka and Accili, 1999). 
Insulin inhibits both cAMP-dependent protein kinase A (PKA) and AMP-activated 
protein kinase (AMPK), which are two enzymes responsible for phosphorylation and 
thus activation of ACC (Allerd and Reily, 1997; Munday, 2002). As for the long-term 
effects, insulin activates the expression of ACC by activating several transcription 
factors, depending on the specific tissue (Kresten, 2001). Transcription factor called 
the sterol regulatory element binding protein-1 (SREBP-1) is the most well defined 
transcription factor that is activated by insulin in both hepatocytes (Kim et al., 1998; 
Zhao et al., 2010) and adipocytes (Fortez et al., 1999) in both ruminants and 
nonruminants (Travers et al., 1997). In turn, activated SREBP-1 activates ACC gene 
transcription (Azzout-Marniche et al., 2000). Several mechanisms have been 
proposed to explain how insulin activates SREBP-1. Azzout-Marniche et al. (2000) 
suggested that SREBP-1 mRNA expression is activated by insulin through a 
phosphatidylinositol 3-kinase-mediated pathway. Direct phosphorylation and 
activation of SREBP-1 by AMPK in the course of insulin signal transduction is a 
second suggested mechanism (Roth et al., 2000). A third mechanism proposed by 
Horton et al. (1998) suggests that the insulin signal activates the proteolytic cleavage 
of membrane-bound SREBP-1 and thus increases the active free form of SREBP-1. 
Up-stream stimulatory factors (USFs) are other transcriptional factors activated by 
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insulin signal and, in turn, stimulate ACC gene expression (Kresten, 2001). In ovine 
adipose tissue, USF bind to the E-box motif, which is a part of the proximal promoter 
of ACC-α gene, and thus activates ACC gene expression (Travers et al., 1997). In 
adipose tissue, a third transcription factor involved in adipocyte differentiation also 
can be activated by insulin signal. That factor is the peroxisome proliferator-activated 
receptor gamma (PPARγ) (Vidal-Puig et al., 1997). PPARγ controls the expression of 
several fatty acid metabolism-related enzymes such as lipoprotein lipase (LPL), fatty 
acid transport protein (FATP), acyl-CoA synthetase (ACS), and PEPCK (Yoon et al., 
2000). In addition, only small fat deposition in the mutant PPARγ mice fed a high 
carbohydrate diet also suggests a lipogenic role of PPARγ (Kubota et al., 1999; Miles 
et al., 2000). 
 ATP-citrate lyase (ACL) also is controlled by short- and long-term effects of 
insulin (Park et al., 1994). As mediated by AMPK, insulin activates ACL by 
increasing phosphorylation of its tryptic peptide A and by decreasing phosphorylation 
of its peptide B (Ramakrishna et al., 1989). Insulin also stimulates ACL gene 
expression through the -104 to -20 bp region of the ACL promoter (Fukuda et al., 
1996).  
 Fatty acid synthase (FAS) is another lipogenic enzyme controlled by insulin 
(Fukuda et al., 1999). Unlike ACC and ACL, insulin does not have a short-term effect 
on FAS; instead, insulin controls FAS at the transcriptional level (Sul and Wang, 
1998). Both USFs and SREBP-1 are involved in insulin stimulation of FAS gene 
expression (Griffin and Sul, 2004). An E-box at -65 was identified in the proximal 
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promoter region of FAS gene (Sawadogo and Roeder, 1985). This E-box was found to 
be associated with insulin activation of FAS expression in mice (Wang and Sul, 1995). 
As for SREBP-1, this protein stimulates FAS gene expression by binding to sterol 
regulator element (SRE) at -150 of the proximal promoter region of the FAS gene 
(Kim et al., 1998). 
 High concentration of insulin also activates GPAT, the enzyme responsible for 
esterification (Shin et al., 1991). Insulin action on GPAT could be mediated by 
SREBP because SREBP binding sites are located in the promoter of the GPAT gene 
(Ericsson et al., 1997). The identification of an E-box at the -320 bp region of the 
GPAT promoter suggests involvement of USFs in GPAT gene expression in response 
to the insulin signal (Jerkins et al., 1995). 
Leptin. Leptin, a hormone produced by adipocytes (Friedman and Halaas, 1998), 
inhibits lipogenesis in porcine (Ramsay, 2003) and ovine adipocytes (Newby et al., 
2001). In their micro-array study, Soukas et al. (2000) showed that many of the 
lipogenic-related genes in mice white adipose tissue such as the FAS, ACL, and 
SREBP-1 genes are all suppressed by leptin. Suppression by leptin suggests the 
involvement of SREBP-1 in leptin suppression of FAS gene expression (Kakuma et 
al., 2000; Nogalska et al., 2005). Recent studies showed that leptin plasma 
concentrations decrease significantly on day 1 postpartum in dairy cows (Sadri et al., 
2010). Decreased leptin concentrations in plasma is accompanied by expression of 
ACC and FAS. 
Glucose. Glucose stimulates lipogenesis by different ways (Kresten, 2001). Glucose 
is a precursor of acetyl-CoA, the primary substrate for the lipogenic pathway; thus, 
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high glucose concentrations stimulate lipogenesis through greater substrate 
availability (Vernon, 1983). Furthermore, high plasma glucose concentrations are 
associated with high insulin concentrations that ultimately stimulate lipogenesis as 
discussed previously (Kresten, 2001). Glucose, however, can stimulate gene 
expression of some lipogenic enzymes in an insulin-dependent manner by recruiting 
the carbohydrate response transcription factor (ChoRF), which binds to the glucose 
response element (GRE) (Foufelle et al., 1996). GRE, a lipogenesis related nuclear 
protein, was identified in the -1601 to -1395 region of the S14 protein gene promoter 
in rat hepatocytes (Shih and Towle, 1994). A homologous sequence to GRE that can 
interact with glucose also was identified in both FAS and pyruvate kinase (PK) genes 
(Foufelle et al., 1996; Koo and Towle, 2000). 
PUFA. PUFA suppress the transcription of several different lipogenic enzymes (Jump 
et al., 1994). The expression of ACC (Fukuda et al., 1992), ACL (Fukuda et al., 1996), 
and FAS (Blake and Clarke, 1990) are all suppressed by PUFA. PUFA control ACL 
gene expression through a PUFA-responsive region in the proximal part of ACL gene 
promoter (Fukuda et al., 1996). As for FAS, PUFA destabilizes the FAS mRNA and 
thus the decay of SREBP-1 mRNA in the cell; this response results in less activation 
of lipogenesis by SREBP-1 (Xu et al., 2001; Howell et al., 2009). 
Lipolysis 
To meet the high energy requirement of milk production and especially during 
the pospartal negative energy balance, adipose tissue accelerates the rates of lipolysis 
just prior to parturition and even more so during early lactation period (McNamara 
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and Hillers, 1986) because of the increased activity of hormone-sensitive lipase (HSL) 
during this peripartal period (McNamara, 1988).Overfeeding cows during the dry 
period increases lipid deposition in adipose tissue. This response to overfeeding 
provides more substrate for lipolytic enzymes during the early postpartal period, and 
thus more NEFA per unit time will be released into the blood (van den Top et al., 
1995). In liver, NEFA are esterified to form TAG, which then are usually released into 
blood in the form of very low density lipoproteins (VLDL) (Gruffat et al., 1996). 
Unusually low release of VLDL results in the accumulation of TAG in liver and 
development of fatty liver disease (Bobe et al., 2004). On the other hand, high 
concentrations of NEFA in blood also result in high concentrations of β- 
hydroxybutyrate, a potent inhibitor of lipolysis (Metz et al., 1972). In addition, 
overfeeding increases the concentrations of insulin (Bobe et al., 2004). Insulin is a 
potent inhibitor of HSL. Thus, insulin could be a major for control of lipolysis in the 
prepartal period (Rukkwamsuk et al., 1998).  
Insulin and catecholamines are the primary hormones available for control of 
lipolysis (Hayrili et al., 2002). Other factors and hormones that affect lipolysis, such 
as glucagon and TNF-α, will be reviewed in a later section of this review of literature. 
Holm et al. (2003) reviewed extensively the regulation of adipocyte lipolysis by 
catecholamines and insulin. Binding of catecholamines like epinephrine and 
norpeinephrine to membrane receptors on the adipocytes stimulate positive coupling 
of Gs protein with adenylyl cyclase for greater production of cAMP. High 
concentrations of cAMP activate PKA, which is responsible for the phosphorylation 
and thus activation of both the HSL and the perilipins (Holm, 2003). Perilipins form a 
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barrier layer by binding to the surface of the lipid droplet; this barrier protects the 
droplet from breakdown by lipases (Londos et al., 1996). However, when 
phosphorylated, the perilipins barrier becomes less tight and allows for initiation of 
the activated HSL to pass through to the surface of the lipid droplet and start the TAG 
hydrolysis action (Souza et al., 1998). Phosphorylated perilipins increase in early 
lactation stage in dairy cows (Elkins and Spurlock, 2009). Insulin, on the other hand, 
inhibits lipolysis by inducing phosphorylation and activation of phosphodiesterase 
type 3B (PDE3B), which can degrade cAMP to 5′ AMP. The diminishing cAMP 
concentrations decrease the PKA activity and, in turn, slow the lipolytic rates 
(Degerman et al., 1997). 
 Adipose triglyceride lipase (ATGL), a recently discovered enzyme that is 
responsible for TAG breakdown to diacylglyceriols (DAG) in mammalian adipose 
tissue, was extensively reviewed (Zechner et al., 2009).  Similar to HSL, β-adrenergic 
stimulation of lipolysis is not accompanied by increased gene expression to ATGL. 
Increased cAMP cellular concentration in response to β-adrenergic stimulation results 
in phosphorylation of perilipin A on fat droplet.  Comparative gene identification-58 
(CGI-58) dissociates from phosphorylated perilipin A and thus activates ATGL. Like 
HSL, insulin down regulates ATGL gene expression; however, the mechanism 
remains unclear.    
Glucagon Treatment Effect 
Because of its ability to increase glucose concentrations in the blood of dairy 
cattle that, in turn, increase plasma insulin concentrations, which ultimately inhibit 
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lipolysis in adipose tissue, glucagon makes a good candidate to treat or prevent fatty 
liver in dairy cattle (De Boer et al., 1986). Glucagon increases plasma glucose 
concentrations by stimulating hepatic gluconeogenesis, glycogenolysis, amino acid 
uptake, and ureagenesis (Flakoll et al., 1994; Donkin and Armentano, 1995). 
Continuous intravenous infusions of glucagon for 14 days to normal lactating dairy 
cattle increased both insulin and glucose concentrations in blood; however, NEFA, 
BHBA, and urea concentrations did not change(She et al., 1999a). According to these 
results, the researchers concluded that glucagon enhanced both glycogenolysis and 
gluconeogenesis but not lipolysis. On the other hand, intravenous infusion of the 
same amount of glucagon for 14 days into cows with the fatty liver condition 
increased glucose concentrations but did not affect the already high blood insulin 
concentrations. The infused glucagon also decreased the glycogen content in the liver 
of those cows (Hippen et al., 1999). Also, glucagon infusions decreased NEFA and 
TAG release into plasma. These results lead to the conclusion that glucagon injections 
alleviate the fatty liver condition by decreasing lipolysis rates (Hippen et al., 1999). In 
the same study, She et al. (1999b) showed that the 14-day glucagon injections into 
normal cows increased plasma insulin; the high insulin, in turn, decreased the PEPCK 
mRNA concentrations within one week. This decrease in PEPCK mRNA, however, 
was not manifested in dairy cows with fatty liver. 
 Because glucagon intravenous infusions are difficult to apply in field 
conditions, Bobe et al. (2003a) investigated the use of subcutaneous glucagon 
injections as an alternative to treat fatty liver condition in dairy cattle. Three equally 
timed subcutaneous glucagon injections for 14 days beginning on day 8 postpartum 
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increased both glucose and insulin concentrations in plasma and decreased plasma 
NEFA concentrations. Liver TAG concentration also was decreased (Bobe et al., 
2003a; Bobe et al., 2007).  Also, the glucagon injection protocol tended to increase 
phospholipids and free cholesterol concentrations in liver when the ambient 
temperature below 35°C but not above 35°. Concentrations of VLDL-TAG, high-
density lipoprotein1- phospholipids, and high-density lipoprotein2-free cholesterol all 
tended to decrease in response to glucagon injections during ambient temperature 
above 35°C. However, during ambient temperature below 35°C, only VLDL-TAG 
tended to decrease (Bobe et al., 2003a; Bobe et al., 2007).  
 The previous research suggested that the use of glucagon could be extended 
from treatment of the fatty liver condition to prevention of the disease in highly 
susceptible dairy cattle. In a later study, Nafikov et al. (2006) investigated the effect 
of subcutaneous injections of glucagon for 14 days to dairy cow, starting the 
injections at day 2 postpartum rather than at day 8 postpartum. The early postpartal 
glucagon injections prevented TAG accumulation in the livers of dairy cows that have 
been subjected to a prepartal fatty liver-promoting diet. Accumulation of TAG 
occurred with untreated cows given the same prepartal diet. In addition, both glucose 
and insulin concentrations in plasma increased in response to the injection, whereas 
NEFA concentrations decreased. This study revealed the effectiveness of 
subcutaneous glucagon injections in preventing fatty liver development in transition 
dairy cattle (Nafikov et al., 2006). Overall, the alleviation or prevention of fatty liver 
in transition dairy cows seems based on particularly gluconeogenesis, lipogenesis, 
and lipolysis in liver and/or adipose tissue. 
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 In his recent study, Osman et al. (2010) investigated the chronic effects of 
subcutaneous injections of glucagon oral administration of glycerol for 14 days to 
dairy cows starting as early as calving rather than at day 2 postpartum. The early 
postpartal glucagon injections increased plasma glucose and plasma glucagon 
concentrations and decreased plasma NEFA concentrations but did not affect plasma 
TAG concentrations. Similar results were recorded when cows treated with both 
glucagon injections and glycerol administration. Oral glycerol decreased plasma 
glucagon concentration; however, it did not affect plasma glucose, NEFA, or TAG 
concentrations. It was concluded that glycerol actually potentiates the glucagon effect, 
and thus glucagon plus glycerol is a more efficient treatment than glucagon injection 
alone. In addition, acute effects of glucagon injections and glycerol administration 
also were measured (Osman et al., 2010) Serial blood samples were collected during 
8-hr period after starting glucagon and/or glycerol treatment. The early postpartal 
glucagon injections increased plasma glucose and plasma glucagon concentration and 
decreased plasma NEFA concentration and increased plasma glucose concentration; 
however, plasma glucagon concentration decreased. It was suggested that glucagon 
and glycerol have additive effects when used together to decrease the incidence of 
diseases developed as a result of high energy status of the cow. 
Gluconeogenesis. Glucagon can increase glucose concentrations in plasma by 
directly activating key enzymes for regulation of gluconeogenesis pathway. Jianag 
and Zhang (2003) extensively reviewed the role of glucagon in regulation of glucose 
metabolism. Glucagon increases the concentrations of cellular cAMP. This change 
leads to the activation of PKA, which, in turn, phosphorylates the cAMP-response 
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element-binding (CREB) protein. This phosphorylated and active form of CREB 
binds to the cAMP-response element in the promoter region of peroxisome 
profilerative receptor-gamma co-activator 1 (PGC-1) gene and thus produces more 
PGC-1 (Herzig et al., 2001). The PGC-1, in turn, recruits the nuclear transcription 
factor hepatocyte nuclear factor-4 (HNF-4) (Yoon et al., 2001) and fork head 
transcription factor (FOXO1) to bind to the PEPCK promoter and induce the PEPCK 
gene expression (Puigserver et al., 2003).  In addition, Hod and Hanson (1988) 
provided evidence that high concentrations of cAMP induced by glucagon actually 
stabilizes the mRNA of PEPCK and thus increases its translation in gluconeogenic 
cells. 
 A cAMP response element was identified in the G6Pase hydrolytic subunit 
gene promoter in H411E hepatoma cells (Schmoll et al., 1999). Furthermore, Thiel et 
al. (2005) indicated the involvement of CREB in the activation of G6Pase in response 
to cAMP. These actions suggest that glucagon regulates both PEPCK and G6Pase in a 
similar pattern. FBPase1, on the other hand, is activated indirectly by glucagon. 
Glucagon activates PKA that, in turn, phosphorylates and inactivates the 
FPK2/FBPase2, resulting in alleviation of the inhibitory effect of fructose (2,6) 
bisphosphate on FBPase1 (Pilkis et al., 1982). 
Lipid Metabolism. Glucagon also is involved in regulation of lipogenesis (Beynen et 
al., 1996). Glucagon activates AMPK, which, in turn, phosphorylates and inactivates 
ACC (Holland et al., 1985; Swenson, 1985). On the other hand, glucagon down 
regulates ACC gene transcription initiated from both promoters 1 and 2 (Hillgartner et 
al., 1997; Yin et al., 2000). As for lipolysis, lipolytic effects of glucagon are more 
18 
 
controversial (Vernon, 1983). Positive lipolytic effects of glucagon in rats were 
demonstrated clearly; physiological concentrations of glucagon, however, showed no 
lipolytic effects in ruminants. A minor lipolytic response was noticed in caprine 
adipose tissue exposed to supra-physiological concentrations of glucagon (Vernon, 
1983). In humans, glucagon infusions in healthy males increased plasma NEFA 
concentrations (Carlson et al., 1993). However, by using the in situ microdialysis 
technique of glucagon administration, other researchers demonstrated that glucagon 
did not affect the lipolysis rates in either human abdominal adipose tissue (Gravholt 
et al., 2001) or human subcutaneous adipose tissue (Bertin et al., 2001).  
 Lipolytic effects of glucagon were reported in different studies by using rat 
(Slavin et al., 1994) and chicken adipocytes (Oscar, 1991). These lipolytic effects 
were mediated by increased intracellular concentrations of cAMP in response to 
glucagon and the subsequent change in the phosphorylation status of HSL and 
ultimately its activation (Slavin et al., 1994). Finally, Slavin et al. (1994) found an 
evidence that glucagon can directly affect the expression of the HSL gene. 
Tumor Necrosis Factor-alpha 
 TNF-α is a 26 kDa plasma membrane-bound monomeric protein (Kriegler et 
al., 1988). The TNF-α is cleaved and secreted by the activity of TNF-α converting 
enzyme (TACE) (Black et al., 1997). TNF-α has two distinct receptors called 1 and 2 
(Loetscher et al., 1990). Both receptors complex with cytoplasmic adapter proteins, 
which, in turn, activate stress-related kinases such as Jun-N-terminal kinase (JNK), 
inhibitor kappa beta kinase beta (IKKβ), MAPK, and protein kinase B/AKT. These 
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proteins control the activity of other transcription factors such as transcription NFκB 
and insulin receptor substrate 1 and 2 (IRS-1 and IRS-2) (Wajant et al., 2003).  
 TNF-α is regulated by different factors like adiponectin produced by 
adipocytes (Fernandez-Real et al., 2003). Vassalli (1992) and Tracey and Cerami 
(1993) reviewed TNF-α interactions with other cytokines. Different cytokines have 
different effects on TNF-α. Interleukin 10 (IL-10), IL-5, and transforming growth 
factor beta (TGFβ) all down regulate TNF-α, whereas interferon gamma (IFNγ) and 
IL-12 activate TNF-α (Vassalli, 1992; Tracey and Cerami, 1993). Elenlkov et al. 
(2000) reviewed TNF-α regulation by neuroendocrine secretions. Norepinephrine, 
epinephrine (van den Poll et al., 1996), histamine (Vannier et al., 1991), and 
adenosine (Prabhakar et al., 1995) all inhibit the production of TNF-α (Elenkov et al., 
2000). 
 In their study, Sordillo et al. (1995) showed that mononuclear cells isolated 
from peripheral blood and supramammary lymph nodes of periparturient dairy cows 
produced more TNF-α than did those cells isolated from mid to late lactating dairy 
cows. Other studies showed that TNF-α concentrations significantly increase in the 
weeks close to parturition (Rontved et al., 2005; Ametaj et al., 2003). On the other 
hand, Kushibiki et al. (2000) established an insulin resistance effect of TNF-α in 
dairy heifers. A high correlation between serum TNF-α concentrations and insulin 
resistance was calculated in dairy cows with fatty livers. This correlation suggests a 
role of TNF-α in the development of insulin-resistance and subsequent fatty liver 
condition in dairy cattle (Ohtsuka et al., 2001). 
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Insulin Resistance. In their reviews, Diehl (2004) and Nieto-Vazquez et al. (2008) 
summarized the molecular mechanisms that TNF-α uses to initiate insulin resistance 
that leads to NAFLD in humans and animals. Briefly, TNF-α activates several stress-
related protein kinases such as JNK, p38 MAPK, IKKβ, protein kinase B/AKT, and 
rapomycin-dependent kinase that control serine phosphorylation of IRS-1 and IRS-2. 
After phosphorylation, the IRSs become less responsive to insulin signal, leading to 
insulin resistance and ultimately NAFLD (Ruan et al., 2003). IKKβ, activated by 
TNF-α, is a complex of several factors; one of them is NFκB that activates TNF-α 
gene transcription (Pauli, 1994). Furthermore, NFκB interacts with and inhibits 
PPARγ; PPARγ is vital for adipocyte differentiation. This inhibition of PPARγ action 
will decrease the differentiation of adipocytes. As a result, adiponectin release 
decreases, and thus its antagonistic activity against TNF-α diminish and cellular 
TNF-α concentrations remain high enough to induce insulin resistance (Ruan et al., 
2003). Adiponectin, on the other hand, inhibits fatty acid uptake in hepatocytes and 
activates lipoprotein export from liver (Yamauchi et al., 2002). Inhibition of 
adiponectin by NFκB induced by TNF-α ultimately leads to more TAG accumulation 
in the liver (Arner, 2003). In a different mechanism, TNF-α activates PTP1B (Nieto-
Vazquez et al., 2008). PTP1B down regulates IRS-1. 
Glucose and Lipid Metabolism. In addition to its direct effect on insulin action, 
TNF-α contributes to insulin resistance indirectly by activating lipolysis and 
increasing the concentrations of plasma NEFA (Green et al., 2004). TNF-α stimulates 
lipolysis by different biochemical mechanisms.  It increases the intracellular 
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concentrations of cAMP. Higher concentrations of cAMP activate PKA, which, in 
turn, phosphorylates perilipins. This phosphorylation will weaken their attachment to 
fat droplet and increase the accessibility for fat droplet to HSL (Souza et al., 2002). In 
rats, TNF-α down regulates the expression of the antilipolytic GTP-binding 
membrane protein Gαi. Decreasing Gαi protein concentrations alleviate their 
inhibitory effect on adenylyl cyclase and ultimately increases the intracellular cAMP 
concentrations (Gasic et al., 1999). In humans, TNF-α uses a different pathway to 
increase cellular cAMP concentrations. TNF-α activates the MAPK including the 
extracellular signal related kinase (ERK)-2 (p42/p44) (Wallach et al., 1999). ERK-2, 
in turn, decreases the expression of cyclic nucleotide phosphodiesterase 3B (PDE3B), 
which decreases cAMP conversion to 5′AMP. This response will increase intracellular 
concentrations of cAMP (Zhang et al., 2002). 
 In 313-L1 cells, TNF-α is shown to use different cellular mechanism to 
stimulate lipolysis. TNF-α directly inhibits perilipin gene expression and thus gives 
HSL more accessibility to fat droplets (Souza, et al., 1998; Souza, et al., 2003). A 
third mechanism that TNF-α uses to increase lipolysis is by directly activating HSL. 
Greenberg et al. (2001) showed that TNF-α signal passes through MAPK and p44/42 
pathway in 313-L1 adipocytes cells to phosphorylate and thereby activate HSL. TNF-
α seems to down regulate ATGL mRNA through a PPARγ inhibition mediated 
mechanism (Zechner et al., 2009). 
 As for lipogenesis, hepatic and adipocytic lipogenesis show opposite response 
to TNF-α. Both ACC and FAS gene expression in adipocytes are down regulated by 
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TNF-α (Doerrler et al., 1994). This down regulation will stop the differentiation of 
pre-adipocytes to fully mature fat cells (Pape and Kim, 1988; Pape and Kim, 1989). 
Hepatic lipogenesis, on the other hand, is stimulated by TNF-α (Grunfeld et al., 1990; 
Grunfeld et al., 1991). TNF-α raises the concentrations of hepatic citrate, which, in 
turn, activates ACC (Grunfeld et al., 1988). Recent studies (Cawthorn and Sethi, 2008) 
should that TNF-α down regulates expression of FFA transport protein (FATP) and 
FFA translocase (FAT). FATP and FAT down regulation result in peroxisomal β-
oxidation inhibition and lipogenesis stimulation (Chen et al., 2009). 
 Finally, the rate of gluconeogensis decreases in response to TNF-α during 
septic shocks (Hill and McCallum, 1992). Daily injection of TNF-α to lactating dairy 
cows increased transcript abundance of G6Pase and PEPCK (Bradford et al., 2009). 
PEPCK gene expression in rat hepatocytes is down regulated when incubated with 
TNF-α (Goto et al., 2001). TNF-α attenuates insulin suppression effect on PEPCK 
gene expression by altering cellular localization of forkhead nuclear transcription 
factor Foxa2 (Pandey et al., 2009). G6Pase gene expression also is decreased in 
H4IIE hepatoma cells when incubated with TNF-α. This response suggests that 
NFκB activation by TNF-α suppresses G6Pase gene expression (Grempler et al., 
2004). 
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CHAPTER 2. EFFECTS OF GLUCAGON, GLYCEROL, AND 
GLUCAGON PLUS GLYCEROL ON GLUCONEOGENESIS, 
LIPOGENESIS, AND LIPOLYSIS IN PERIPARTURIENT 
HOLSTEIN COWS1 
 
A paper to be submitted to the Journal of Dairy Science 
Nimer Mehyar2, Mohammad A. Osman3, Andrew W. Brown2, Danijela Kirovski4, 
Portia S. Allen5, Rafael A. Nafikov2, Johann F. Coetzee6, Kenneth J. Koehler7, and 
Donald C. Beitz2,8  
 
Abstract 
 The objective of this study was to investigate the effect of daily glucagon 
subcutaneous injections of 15 mg and oral administration of 400 mL glycerol during 
the first 14 d postpartum on the rates of gluconeogenesis in liver and lipogenesis and 
lipolysis in adipose tissues obtained from dairy cows with fatty liver syndrome (FLS). 
To induce FLS, 16 multiparous cows with body condition score of ≥ 3.5 (1-5 scale) 
cows were daily fed dry-cow ration plus 6 kg of cracked corn during the last 6 weeks 
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of dry period. Cows were assigned equally and randomly to 4 treatment groups: saline, 
glycerol, glucagon, and glucagon plus glycerol. Liver and adipose tissue slices were 
incubated with 10 nM glucagon and 1 nM tumor necrosis factor-alpha (TNF-α). 
Glucose synthesis rates from propionic acid and alanine were measured in liver, and 
glycerol release rates and fatty acid synthesis rates were measured in adipose tissues. 
Glucagon injections and glycerol oral administration did not affect the rates of 
gluconeogensis or lipolysis. Lipogenesis rates tended to decrease with glucagon and 
glycerol treatments. Incubation of adipose and liver tissues with TNF-α and glucagon 
did not affect glucose synthesis rates or fatty acid breakdown or synthesis in adipose 
tissue. We conclude that glucagon and glycerol treatments alleviate the symptoms of 
FLS by long-term effects rather than direct effects on liver or adipose metabolic 
pathways. 
Introduction 
FLS is a metabolic disorder that affects dairy cows during the transition stage 
between late prepartal and early postpartal periods (Drackley, 1999). With a 
prevalence up to 54% (Jorritsma et al., 2001) and a morbidity and mortality up to 90% 
and 25%, respectively (Raoofi et al., 2001), FLS causes a major economic loss for 
U.S dairy farmers (Littledike et al., 1981). FLS increases the risks of other 
periparturient diseases including ketosis, endometritis, retained fetal membranes, 
displaced abomasums, mastitis, and milk fever (Katoh, 2002; van Winden et al., 
2003). Decreased reproductive success (Jorritsma et al., 2000) and suppressed 
immune functions (Wentink et al., 1999) are long-term effects of FLS. Between low 
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dry matter intake (DMI), 70% of normal, and increased demand for glucose at the 
onset of lactation, transition dairy cows develop negative energy balance (NEB) 
(Herdt, 2000). To meet nutrient and energy requirements under NEB status, the dairy 
cow mobilizes fatty acids reserves in adipose tissue, which results in NEFA 
accumulation in blood (Grummer, 1993; Drackley, 1999). Blood NEFA are mainly 
taken up by the liver where they are either oxidized in mitochondria to produce 
energy or esterified into triacylglycerol (TAG). Triacylglycerol is either directly 
stored in liver or released in blood in the form of TAG-rich very low density 
lipoproteins. When the rate of TAG storage in liver is higher than rates of NEFA 
oxidation to CO2 and to ketone bodies and rates of TAG-rich very low density 
lipoprotein release, then FLS develops (Grummer, 1993).  
TNF-α concentrations significantly increase before parturition (Rontved et al., 
2005; Ametaj et al., 2003). Serum TNF-α concentrations are highly correlated with 
insulin resistance in dairy cows with fatty livers (Kushibiki et al., 2000). This 
correlation suggests a role of TNF-α in the development of insulin resistance and 
subsequent fatty liver condition in dairy cattle (Ohtsuka et al., 2001). High TNF-α 
concentration increases insulin resistance by triggering insulin receptor substrates 
(IRSs) phosphorylation (Ruan et al., 2003) and stimulates lipolysis by increasing 
hormone-sensitive lipase (HSL) accessibility to fat droplet (Souza et al., 2002). 
Adipose tissue is the major site of lipogenesis in ruminants (Bauman, 1976); de novo 
lipogenesis in adipose contributes only to about 30-35% of adipose deposition in 
ruminants (Vernon, 1983); the remainder of stored triacylglycerol (TAG) is derived 
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from the diet. The contribution of de novo lipogenesis to fatty liver development in 
ruminants, however, remains unclear. 
Feeding high energy diets, feeding glucogenic precursors or slow-release 
insulin treatments do not alleviate FLS conditions (Hayrili et al., 2002; Douglas et al., 
2004; Hoedemaker et al., 2004). Multiple glucagon intravenous infusions (Hippen et 
al., 1999) or subcutaneous injections (Bobe et al., 2003a) could treat or prevent 
(Nafikov et al., 2006) experimentally induced FLS by up regulating gluconeogenesis 
(She et al., 1999) and down regulating adipose tissue lipolysis (Hippen et al., 1999). 
Glucagon injections induce gene expression of phosphoenolpyruvate carboxykinase 
and pyruvate kinase in early lactating cows (Bobe et a., 2009). When co-administered 
with glucagon subcutaneous injections, oral glycerol potentiates glucagon preventive 
action (Osman et al., 2008; Osman et al., 2010). Orally administered glycerol is 
metabolized in the rumen and liver to VFA and in liver to intermediates of 
gluconeogenesis and glycolysis (Remond et al., 1993; Goff and Horst, 2001; Osman 
et al., 2008).  
The effect of glucagon on gluconeogenesis, lipogenesis, and lipolysis was 
determined by measuring blood concentrations of glucose, NEFA, TAG, and BHBA. 
The effect of glucagon injections on the rates of these pathways, however, is still to 
be determined. Therefore, we hypothesized that subcutaneous injection of glucagon 
alleviates FLS symptoms by affecting the rates of gluconeogenesis in liver and the 
rates of lipolysis and lipogenesis in adipose tissue directly. The objective of this study 
is to measure the rates of the three metabolic pathways before and after glucagon 
treatment and under different hormonal factors such as TNF-α and epinephrine.  
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Materials and Methods 
Experimental Design 
The experimental design was described previously (Osman et al., 2008). 
Briefly, 16 multiparous Holstein cows with a BCS ≥3.5 were selected from the Iowa 
State University dairy herd. Experimental FLS was induced by giving cows ad 
libitum access to a dry-cow TMR supplemented with 6 kg of cracked corn during the 
last 6 wk of the dry period. Right after parturition, experimental cows were housed in 
a sand-bedded tie stall and offered ad libitum access to an NRC (2001) recommended 
TMR for high-producing dairy cows twice a day. Four hours after parturition, 16 
cows were injected with 60 mL of 0.9 M NaCl solution (pH 10.25) that contained 
either 0 (control: n = 4; glycerol: n = 4) or 5 (glucagon: n = 4; glucagon plus glycerol: 
n = 4) mg of glucagon. Cows were injected s.c every 8 h for 13 d and 16 h apart on d 
14 and received a single injection on d 15 postpartum. Glycerol-treated cows received 
orally 400 mL of pure glycerol (West Central Inc., Ralston, IA) diluted with 100 mL 
of water once a day at 0600 h for 14 d. The presented results are from 14 cows that 
had prepartal liver samples. The remaining 6 cows in the study calved before they 
were expected, and thus no prepartal liver sample had been collected. All the 
experimental and surgical procedures used in this study were approved by the Iowa 
State University Institutional Animal Care and Use Committee. 
Liver and Adipose Samples 
Liver samples were collected 4 days before calving and 9 days after calving. 
Cows were anesthetized locally with lidocaine and a biopsy needle was inserted 
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through a 12 to 15 mm incision made through the skin at either the 11th or 12th 
intercostal space. Liver biopsy was monitored by ultrasound (Aloka Micrus 500, 
Corometrics Inc., Wallingford, CT) to avoid puncture of internal organs and any 
major blood vessel. About two grams of liver tissue were collected at each entry of 
the body. About two grams were frozen in liquid nitrogen (-80 °C) for DNA 
quantitation. The liver sample used for incubation was stored on ice in a 150 mM 
sodium chloride, 150 mM sodium phosphate (pH 7.2) solution. Adipose tissue was 
collected from the tail head region after local anesthesia with lidocaine 7 days before 
calving and 4 days after calving and stored in phosphate-buffered saline at 37 °C for 
less than 30 min until incubations.  
Incubation Procedures 
Incubation procedures to measure gluconeogenesis rates have been previously 
described (Mills et al., 1986). Briefly, thin slices of liver tissue (80-150 mg) were 
incubated for 2 hr at 37 °C in 3 mL of calcium-free Krebs-Henseleit buffer (pH 7.4) 
containing 30 µmol of alanine or propionic acid and at least 1 µCi of L[1,3-14C] 
alanine or L[3-14C] propionic acid . Treatments were added either 1 nM rec-TNF-α or 
10 nM glucagon. Reactions were stopped by 1 M perchloric acid. Incubations 
continued for another hour to collect CO2 on filter papers treated with 10% NaOH. 
After CO2 collection, media were neutralized with 2 M potassium carbonate. About 
0.1 µCi of [6-3H] glucose was added to media as internal standard. Glucose was 
isolated by ion-exchange chromatography (Mills et al., 1986). Finally, radioactivity in 
both CO2 collection filter papers and glucose containing fractions were determined 
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with a scintillation spectrophotometer. 
To measure lipogenesis rates, sections of adipose tissue (80-150 mg) were 
incubated for 2 hr at 37 °C in 3 mL of calcium-free Krebs-Henseleit buffer (pH 7.4) 
(Whitehurst et al., 1978). In addition to 1 nM rec-TNF-α or 10 nM glucagon 
treatments, 5 mM glucose, 25 mM sodium acetate, and 1 µCi of acetic acid-1-14C also 
were added to the incubation mixture. Incubations were stopped by 1 M sulfuric acid, 
and CO2 was collected on filter papers soaked in 10% NaOH. Adipose tissues were 
separated from media by filtration, and then lipids were extracted from tissue (Folch 
et al., 1957). Radioactivity in extracts was determined by a scintillation 
spectrophotometer. 
To measure lipolyis rates, sections of adipose tissues (80-150 mg) were 
incubated in 3 mL calcium-free Krebs-Henseleit buffer (pH 7.4) with 5 mM glucose 
and 3% bovine serum albumin for 2 hours at 37 °C. Three treatments were added to 
separate flasks: 1 nM rec-TNF-α, 10 nM glucagon, and 1.5 µM of epinephrine. 
Reactions were stopped by placing the reaction media on ice (DiMarco et al., 1986). 
Lipolysis rates were determined by quantifying the free glycerol in media (kit number 
F 6428, Sigma, St. Louis, MO). 
Statistical Analysis 
 Data were analyzed as repeated measures by using the mixed model procedure 
(PROC MIXED) in the SAS Version 9.1.3 (SAS Institute Inc., Cary, NC). Effects of 
different cow treatments on rates of gluconeogenesis, lipogenesis, and lipolysis were 
evaluated by comparing each group with saline (control) group. Separate comparisons 
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were used for data obtained during the prenatal and postnatal periods of treatment. 
Least square means were calculated, and significance was declared at P<0.05. 
Results 
Gluconeogenesis 
 To study acute effects of TNF-α and glucagon within cow treatment groups on 
gluconeogenesis, livers were incubated with either propionic acid or alanine as 
glucose precursors. Liver tissues incubated with propionic acid produced significantly 
more glucose than did those incubated with alanine (Table 1). This substrate effect 
was observed in all cow treatment groups and tissue treatment subgroups (p < 0.0001). 
Livers from control cows and cows treated with glycerol have faster glucose synthesis 
rates from propionic acid in post-calving stage than those of pre-calving stage. This 
result was not the case for cows treated with glucagon or glucagon plus glycerol. 
Parturition did not affect glucose synthesis rates from alanine. Incubating liver tissues 
with TNF-α or glucagon did not affect glucose synthesis rates when propionic acid (p 
≤ 0.85) or alanine (p ≤ 0.36) was used as precursor. This effect is true for all cow 
treatment groups in the pre- and post-calving periods. 
 Oxidative capacity of liver was determined by measuring the rates of 
oxidation of propionic acid and alanine to CO2. Opposite to substrate specificities for 
glucose production rates, tissues incubated with alanine as substrate  released more 
CO2 than did those incubated with propionic acid (p < 0.0001) (Table 2). This effect 
is true for all cow treatment groups and substrate treatment subgroups. Glucagon or 
glucagon plus glycerol treatments did not affect the rates of propionic acid (p ≤ 0.11) 
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or alanine (p ≤ 0.75) oxidation to CO2. Propionic acid and alanine oxidation to CO2 
tend to increase after parturition. This tendency was significant for control cows, but 
not statistically significant (P > 0.05), for glycerol treatment cows when propionic 
acid was used as a substrate. Treatment of liver tissues with TNF-α or glucagon did 
not affect the rate of oxidation of either substrate to CO2 (propionic acid, p ≤ 0.68, 
and alanine, p ≤ 0.96). This effect was true for all cow treatment groups. 
 Despite the increased glucose production rates after calving, ratio of  rate of 
propionic acid or alanine oxidation to CO2 to rate of propionic acid or alanine 
conversion to glucose was not significantly affected by calving (p ≤ 0.45) , cow 
treatment (p ≤ 0.55), or TNF-α and glucagon treatments (p ≤ 0.32) (Table 3). In 
general, rates of propionic acid oxidation to CO2 were 6.4% of rates of propionic acid 
conversion to glucose. Rates of alanine oxidation to CO2 were 160% of rate of 
alanine conversion to glucose. 
Lipolysis 
 Acute effects of TNF-α and glucagon on lipolysis were measured in the 
presence and absence of epinephrine as a stimulant of maximal lipolysis of adipose 
tissue. Epinephrine stimulated glycerol release from adipose tissue obtained from 
different cows subjected to different treatments (p < 0.0001) (Table 4). For all cow 
and adipose tissue treatments, epinephrine resulted in a 1.6-fold increase in rates of 
lipolysis. During the pre-calving period or the post-calving period, there was no 
significant difference in the rate of glycerol release among the four cow treatment 
groups whether epinephrine was present (p ≤ 0.19) or absent (p ≤ 0.38). Generally,
 Table 1. Rates of glucose synthesis from propionic acid and alanine in liver (nmol glucose /hr*mg DNA ± SE)1 
Cow treatment Liver tissue treatment 
Propionic acid  Alanine 
Pre-calving Post-calving SEM2 P3 Pre-calving Post-calving SEM2 P3 
Saline Control 1212 a 2849 b  704 0.02 40 a 94 b 308 0.73 
TNF-α 941 a 2450 b  704 0.03 43 a 68 b 308 0.94 
Glucagon 1087 a 2526 b  704 0.04  43 a 69 b 308 0.93 
          
Glycerol Control 722 a 2379 b  787 0.04 30 a 66 b 308 0.91 
TNF-α 587 a 2531 b  787 0.02 24 a 79 b 308 0.86 
Glucagon 590 a 2977 b  787 0.003 27 a 100 b 308 0.81 
          
Glucagon Control 1658 a 1715 b  787 0.94 57 a 68 b 275 0.97 
TNF-α 1544 a 1598 b  787 0.95 71 a 76 b 275 0.99 
Glucagon 1688 a 1063 b  787 0.43 67 a 104 b 275 0.91 
          
Glucagon and 
glycerol 
Control 1103 a 1792 b  643 0.29 36 a 87 b 275 0.85 
TNF-α 747 a 1980 b  643 0.06 33 a 102 b 275 0.80 
Glucagon 812 a 1681 b  643 0.18 39 a 99 b 275 0.83 
1Liver was obtained from cows treated with saline, glycerol, glucagon, or glucagon plus glycerol. Tissues were either controls or treated with 1 nM rec-
TNF-α or 10 nM glucagon. 
2 SEM represents the standard error for the difference between the post-calving means within combinations of cow and liver treatment.  
3P Represents the p-value for the t-test of the null hypothesis of no difference between pre and post-calving means within combination of cow and liver 
treatments. 
a-b
 Within a column, means with different superscripts differ (P<0.05). 
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Table 2. Rates of oxidation of propionic acid and alanine to CO2 in liver (nmol CO2 /hr*mg DNA ± SE)1 
Cow treatment Liver tissue treatment 
Propionic acid  Alanine 
Pre-calving Post-calving SEM2 P3 Pre-calving Post-calving SEM2 P3 
Saline Control 14 a 427 b  117 0.001 296 a  1056 b  218 0.001 
TNF-α 12 a 92 b  117 0.50 340 a  707 b 218 0.10 
Glucagon 18 a  272 b  117 0.03 377 a  1113 b  218 0.001 
          
Glycerol Control 26 a  165 b  130 0.29 363 a  523 b 218 0.47 
TNF-α 31 a  223 b  130 0.14 530 a  480 b  218 0.82 
Glucagon 18 a  204 b  130 0.16 366 a  386 b 218 0.93 
          
Glucagon Control 32 a  109 b  107 0.56 527 a  642 b 195 0.60 
TNF-α 33 a  96 b 107 0.63 716 a  380 b 195 0.13 
Glucagon 34 a  64 b  107 0.81 621 a  398 b  195 0.31 
          
Glucagon and 
glycerol 
Control 11 a  60 b 107 0.65 274 a  537 b 195 0.18 
TNF-α 11 a  45 b  107 0.75 323 a  576 b 195 0.20 
Glucagon 13 a  62 b  107 0.65 162 a  663 b 195 0.01 
1Liver was obtained from cows treated with saline, glycerol, glucagon, or glucagon plus glycerol. Tissues were either controls or treated with 1 nM rec-
TNF-α or 10 nM glucagon. 
2 SEM represents the standard error for the difference between the post-calving means within combinations of cow and liver treatment.  
3P Represents the p-value for the t-test of the null hypothesis of no difference between pre and post-calving means within combination of cow and liver 
treatments. 
a-b
 Within a column, means with different superscripts differ (P<0.05). 
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Table 3. Ratio of oxidation of propionic acid or alanine to CO2 to rates of glucose synthesis from propionic acid or alanine in liver.1 
Cow treatment Liver tissue treatment 
Propionic acid  Alanine 
Pre-calving Post-calving SEM2 P3 Pre-calving Post-calving SEM2 P3 
Saline Control 0.02 a  0.27 b  0.15 0.11 13 a  7 b  6.0 0.81 
TNF-α 0.02 a  0.04 b  0.15 0.13 14 a  11 b  6.0 0.47 
Glucagon 0.03 a  0.14 b  0.15 0.93 17 a  25 b  6.0 0.26 
          
Glycerol Control 0.04 a  0.10 b  0.10 0.32 19 a  18 b  6.0 0.82 
TNF-α 0.06 a  0.11 b  0.10 0.92 29 a  22 b  6.0 0.54 
Glucagon 0.03 a  0.08 b  0.10 0.26 19 a  24 b  6.0 0.41 
          
Glucagon Control 0.02 a  0.06 b  0.17 0.52 19 a  14 b  8.0 0.56 
TNF-α 0.03 a  0.06 b  0.17 0.47 14 a  14 b  8.0 0.83 
Glucagon 0.02 a  0.07 b  0.17 0.16 17 a  14 b  8.0 0.44 
          
Glucagon and 
glycerol 
Control 0.03 a  0.07 b  0.13 0.41 12 a  12 b  8.0 0.56 
TNF-α 0.03 a  0.06 b  0.13 0.51 16 a  15 b  8.0 0.68 
Glucagon 0.03 a  0.11 b  0.13 0.87 10 a  10 b  8.0 0.91 
1Liver was obtained from cows treated with saline, glycerol, glucagon, or glucagon plus glycerol. Tissues were either controls or treated with 1 nM rec-
TNF-α or 10 nM glucagon. 
2 SEM represents the standard error for the difference between the post-calving means within combinations of cow and liver treatment.  
3P Represents the p-value for the t-test of the null hypothesis of no difference between pre and post-calving means within combination of cow and liver 
treatments. 
a-b
 Within a column, means with different superscripts differ (P<0.05). 
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Table 4. Rates of glycerol release from adipose tissues (nmol glycerol /hr*g tissue ± SE)1 
Cow treatment Liver tissue treatment 
Epinephrine (-)2  Epinephrine (+)3 
Pre-calving Post-calving SEM4 P5 Pre-calving Post-calving SEM4 P5 
Saline Control 204 a  166 b  91 0.56 478 a  314 b  87 0.07 
TNF-α 216 a  164 b  96 0.47 339 a  306 b  87 0.71 
Glucagon 334 a  170 b  96 0.51 503 a  261 b  87 0.01 
          
Glycerol Control 283 a  211 b  91 0.44 420 a  281 b  84 0.09 
TNF-α 167 a  178 b  91 0.91 446 a  229 b  84 0.01 
Glucagon 288 a  171 b  91 0.20 409 a  252 b  79 0.05 
          
Glucagon Control 137 a  184 b  111 0.68 279 a  200 b  97 0.42 
TNF-α 137 a  162 b  111 0.83 274 a  274 b  97 0.55 
Glucagon 130 a  157 b  111 0.81 243 a  205 b  97 0.70 
          
Glucagon and 
glycerol 
Control 240 a  223 b  128 0.82 377 a  232 b  97 0.12 
TNF-α 257 a  178 b  128 0.54 422 a  217 b  97 0.04 
Glucagon 236 a  161 b  146 0.56 364 a  175 b  97 0.06 
1Adipose was obtained from cows treated with saline, glycerol, glucagon, or glucagon plus glycerol. Tissues were either controls or treated with 1 nM 
rec-TNF-α or 10 nM Glucagon. 
2-3
 (-): No epinephrine was added to the incubations; (+):1.5 µM of epinephrine was added to the incubations 
4 SEM represents the standard error for the difference between the post-calving means within combinations of cow and adipose treatment.  
5P Represents the p-value for the t-test of the null hypothesis of no difference between pre and post-calving means within combination of cow and 
adipose treatments. 
a-b
 Within a column, means with different superscripts differ (P<0.05). 
52
 
53 
 
glycerol release decreased after calving; this effect, however, was usually significant 
only (p < 0.05) in the presence of epinephrine stimulation. Incubating adipose tissues 
from all cows with either TNF-α or glucagon did not affect glycerol release rates; this 
lack of effect of TNF-α and glucagon was observed in either presence (p ≤ 0.84) or 
absence (p ≤ 0.73) of epinephrine. 
Lipogenesis 
 To study acute effects of TNF-α and glucagon on de novo lipogenesis, adipose 
tissues were incubated with acetate as a fatty acid precursor. During the pre-calving 
period or post-calving period, there was no significant difference (p > 0.05) in the rate 
of lipogenesis among the four cow treatment groups (p ≤ 0.80) (Table 5). The rates of 
lipogenesis in adipose tissue of pre-parturient cows were greater than those of post-
parturient cow. In general, rates were 6.5 times greater before calving. This difference 
was more pronounced in tissues obtained from cows treated with glycerol or glucagon 
plus glycerol. Incubating adipose tissues from all cows with either TNF-α or 
glucagon did not affect palmitate synthesis rates (p ≤ 0.76). 
 To study acute effects of TNF-α and glucagon on oxidative capacity of 
adipose tissue, the rates of oxidation of acetate to CO2 were quantified. Cow 
treatments, whether during the pre-calving period or post-calving period, did not 
affect CO2 release when acetate was used as a substrate (p ≤ 0.74) (Table 6). In 
addition, TNF-α or glucagon treatment of adipose tissues did not affect the rate of 
acetate oxidation to CO2 (p ≤ 0.19). The ratio of acetate oxidation to CO2 to rate of 
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Table 5. Rates of acetate conversion to long-chain fatty acids in adipose tissue (nmol acetate 
converted to fatty acids /hr*g tissue ± SE)1 
Cow treatment 
Adipose 
tissue 
treatment 
Lipogenesis 
Pre-calving Post-calving SEM2 P3 
Saline Control 78 a  15 b  41 0.08 
TNF-α 75 a 17 b  36 0.11 
Glucagon 53 a 15 b  36 0.24 
Glycerol Control 99 a  19 b  32 0.02 
TNF-α 101 a  17 b  32 0.01 
Glucagon 108 a  21 b  32 0.01 
Glucagon Control 86 a  12 b  40 0.07 
TNF-α 89 a  11 b  40 0.06 
Glucagon 71 a  12 b  40 0.15 
Glucagon and 
glycerol 
Control 122 a  14 b  42 0.01 
TNF-α 160 a  13 b  42 0.001 
Glucagon 112 a  12 b  42 0.01 
 
1Adipose was obtained from cows treated with saline, glycerol, glucagon, or glucagon plus glycerol. 
Tissues were either controls or treated with 1 nM rec-TNF-α or 10 nM glucagon. 
2 SEM represents the standard error for the difference between the post-calving means within combinations 
of cow and adipose treatment.  
3P Represents the p-value for the t-test of the null hypothesis of no difference between pre and post-calving 
means within combination of cow and adipose treatments. 
a-b
 Within a column, means with different superscripts differ (P<0.05). 
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acetate conversion to long-chain fatty acids significantly increased in the post-calving 
cows treated with glucagon only. The ratios were not affected by TNF-α or glucagon 
treatment of adipose tissues (p ≤ 0.44). The average ratio for pre-calving cows was 
2.05, and that for post-calving cows was 8.94. This 4.4-fold difference, however, was 
not significant.  
Discussion 
 The objective of the current study was to measure the effect of subcutaneously 
administered glucagon for 14 days, starting at day 2 after calving, to dairy cows 
highly susceptible to fatty liver development on the rates of different metabolic 
pathways, specifically, gluconeogenesis, lipolysis, and lipogenesis, under the in vitro 
effect of different hormonal and substrate treatments. Propionic acid conversion to 
glucose is 10 to 35 times faster than that for alanine. These ratios agree with those 
observed in previous reports (Mills et al., 1986; Overton et al., 1999; Wladron et al., 
2003). In these reports propionic acid conversion to glucose is shown to be 5 to 25 
more than that of alanine. Propionic acid and alanine oxidation rates to CO2 were in 
the same ranges of those reported previously (Mills et al., 1986). In agreement with 
previous studies, the ratios of propionic acid oxidation to CO2 to glucose synthesis 
rates are much smaller that those of alanine (Mills et al., 1986; Veenhuizen et al., 
1991; Donkin and Armentano, 1994; Piepenbrink et al., 2004). 
 Based on the increased blood glucose concentrations (Bobe et al., 2003b; 
Nafikov et al., 2006; Osman et al., 2008), and increased expression of gluconeogenic 
enzymes (Bobe et al., 2009) after glucagon injections, glucagon injections in early 
  
Table 6. Rates of acetate oxidation to CO2 (nmol CO2 nmol/hr*g tissue ± SE) and ratio of rate of acetate oxidation to CO2 to rate of acetate 
conversion to long-chain fatty acids in adipose tissue.1 
Cow treatment 
Adipose 
tissue 
treatment 
Oxidation to CO2  Oxidation to CO2/lipogenesis 
Pre-calving Post-calving SEM2 P3 Pre-calving Post-calving SEM2 P3 
Saline Control 74 a  53 b  28 0.41 1.5 a  4.1 b  5.4 0.60 
TNF-α 83 a  96 b  25 0.60 1.9 a  7.6 b  4.8 0.23 
Glucagon 72 a  62 b  25 0.98 2.4 a  4.3 b  4.8 0.59 
          
Glycerol Control 81 a  104 b  23 0.30 2.5 a  6.3 b  4.4 0.38 
TNF-α 101 a  115 b  23 0.53 2.8 a  5.3 b  4.4 0.36 
Glucagon 122 a  85 b  23 0.11 2.5 a  5.2 b  4.4 0.54 
          
Glucagon Control 90 a  133 b  28 0.13 2.5 a  23 b  5.8 0.0003 
TNF-α 139 a  115 b  28 0.40 2.9 a  17 b  5.8 0.01 
Glucagon 84 a  85 b  28 0.97 2.0 a  18 b 5.8 0.04 
          
Glucagon and 
glycerol 
Control 104 a  81 b  31 0.50 1.3 a  5.3 b  5.8 0.41 
TNF-α 88 a  88 b  31 0.94 1.1 a  5.8 b  5.8 0.35 
Glucagon 76 a  108 b  31 0.26 1.2 a  7.9 b  5.8 0.20 
1Adipose was obtained from cows treated with saline, glycerol, glucagon, or glucagon plus glycerol. Tissues were either controls or treated with 1 nM 
rec-TNF-α or 10 nM glucagon. 
2 SEM represents the standard error for the difference between the post-calving means within combinations of cow and adipose treatment.  
3P Represents the p-value for the t-test of the null hypothesis of no difference between pre and post-calving means within combination of cow and 
adipose treatments. 
a-b
 Within a column, means with different superscripts differ (P<0.05). 
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lactation period are predicted to activate gluconeogenesis. Contrary to previous 
studies, gluconeogenesis rates measured by propionic acid and alanine conversion to 
glucose were not affected by glucagon injections. Furthermore, livers obtained from 
cows that did not receive glucagon treatment utilized propionic acid at greater rates 
than those who received glucagon injections. High individual variations among cows 
in addition to the low number of cows per cow treatment group make it difficult to 
draw final conclusions about the effect of glucagon injections on the rates of 
substrates conversion to glucose.  
 Nevertheless, the possibility of gluconeogenesis inhibition by elevated insulin 
concentrations in glucagon-treated cows can not be excluded. Glucagon subcutaneous 
injections result in increased insulin concentrations in plasma (Bobe et al., 2003b; 
Nafikov et al., 2006; Osman, et al., 2008). Insulin suppresses PEPCK activity in 
hepatoma cells (Beale et al., 1986; Granner et al., 1983). Insulin specifically 
decreases glucose synthesis rates from propionic acid versus lactate in neonatal 
bovine livers (Donkin and Armentano, 1994). Low plasma insulin concentrations in 
the post-parturition period of glycerol and control group (Osman et al., 2008) 
decreases the potential insulin inhibitory effect on gluconeogenesis in livers obtained 
from cows in these of two groups. Weak inhibitory effect of insulin on gluconeogenic 
enzymes in these two groups may explain higher propionic acid conversion rates 
compared with those in cows treated with glucagon or glucagon plus glycerol. This 
observation is consistent with previous findings that PEPCK mRNA concentrations 
increased significantly in the livers of cows experiencing low insulin concentrations 
as a result of feed restriction (Velez and Donkin, 2005). In accordance with previous 
58 
 
observations, increased oxidation rates in control and glycerol treatment cows can 
also be explained by the absence of insulin inhibitory effect on gluconeogenesis in 
these two groups. Propionic acid or alanine carbon repartitioning between 
gluconeogenesis and oxidation through TCA cycle was not affected by glucagon 
injections.  
 Addition of 10 nM glucagon to liver slices did not increase glucose synthesis 
rates from propionic acid or alanine. This observation is consistent with previous 
reports of ineffectiveness of glucagon to increase glucose synthesis rates from 
propionic increase significantly in ovine (Looney et al., 1987) or bovine (Donkin and 
Armentano, 1993) hepatocyte cultures. It was suggested, however, that hepatocyte 
isolation procedure could have resulted in an impaired signal transduction system 
(Donkin and Armentano, 1993). In another study, glucagon concentration of 1 nM 
increased the Vmax of propionic acid conversion to glucose when added to cultures 
of monolayer of neonatal bovine hepatocytes (Donkin and Armentano, 1994). Short-
term administration of glucagon to midlactation dairy cows did not increase 
expression of gluconeogenic enzymes or increase rates of propionic acid conversion 
to glucose (Williams et al., 2006). Less accessibility of glucagon to incubated liver 
tissues is another possible factor that can result in lowered effects of glucagon. 
Similarly, the lack of TNF-α on gluconeogensis can be explained by less responsive 
or inaccessible signal transduction system in directly obtained liver tissues. Adding 
1.2 nM TNF-α to rat hepatocyte cultures did not decrease glucose synthesis rates 
from alanine or lactate (Rofe et al., 1987).  
 To measure effects of glucagon subcutaneous injections of glucagon on 
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adipose tissue lipolysis, glycerol release rates were determined by in vitro 
experiments. Glycerol release rates reported in current study are either in agreement 
or are 2 to 5 fold lower than the rates cited in several previous reports (Vernon, 1983; 
McNamara and Hillers, 1986a; McNamara and Hillers, 1986c; McNamara, 1988; 
McNamara, 1989; DiMarco et al., 1991; McNamara et al., 1992; Rukkwamsuk et al., 
1998; Lanna and Bauman, 1999; McNamara and Valdez, 2005). Relatively lower 
lipolysis rates in this study can be explained by prolonged inhibition of lipolysis by 
relatively higher than normal insulin concentrations in plasma (Dann et al., 2006). 
Feeding cows high energy diets during dry period is usually associated with relatively 
higher insulin concentrations than normally fed cows (van den Top et al., 1995; 
Rukkwamsuk et al., 1998; de Feu et al., 2009). Insulin inhibits lipolysis by decreasing 
cAMP cellular concentrations by inhibiting adenylyl cyclase (Lambert and Jacquemin, 
1979), activating phosphodiesterase (Kono et al., 1975), or both (Vernon, 1983). 
Decreasing active phosphorylated HSL concentrations by activating protein 
phosphatase is another suggested mechanism explains insulin inhibitory effect on 
lipolysis (Strålfors and Honnor, 1989). Although epinephrine impact on in vitro 
glycerol release rates was significant in the current study, this effect is lower than that 
in previous reports (Bauman, 1976). Relatively high insulin concentrations because of 
high energy feeding can explain the attenuated glycerol release rates in response to 
adipose tissue treatment with epinephrine.  Previous in vitro studies (Yang and 
Baldwin, 1973) showing that insulin decreased epinephrine-stimulated lipolysis rates 
by 10-25% are consistent with the attenuated lipolysis response to epinephrine 
observed in our experiment. 
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 Parturition effect on lipolysis was not statistically significant for all cow and 
adipose tissues treatments; however, when stimulated by epinephrine, lipolysis rates 
tended to decrease in the post-calving stage in saline-treated or control cows. Lower 
glycerol release rates in postpartal versus prepartal stage can be attributed to the low 
responsiveness of adipose tissue to epinephrine in late pregnancy and early 
postpartum compared with mid-lactation times (McNamara, 1988). On the other hand, 
elevated BHBA concentrations in plasma in the first pospartal week in saline group 
(Osman et al., 2010) may inhibit lipolysis in the pospartal stage. In vitro incubation of 
bovine adipose tissue with BHBA significantly decreased glycerol release rate (Metz 
et al., 1974). Increased plasma BHBA concentration because of rumen glycerol 
fermentation (DeFrain et al., 2004; Osman, et al., 2010) explains the lowered lipolysis 
rates adipose tissues obtained from cows treated with glycerol or glycerol plus 
glucagon in the postpartal stage. Postpartal glucagon injections decreased BHBA 
plasma concentrations significantly in cows treated with glucagon only. Glucagon 
alleviated BHBA inhibitory effect on lipolysis in adipose tissues obtained from cows 
treated with glucagon only. 
 Short incubation time (2 hr) of adipose tissue with 1 nM TNF-α can explain 
the lack of response to TNF-α. Incubating isolated rat adipocytes with 1.2 nM TNF-α 
for a time range from 30 to 120 min did not affect glycerol release (Rofe et al., 1987); 
however, incubating isolated rat adipocytes with 4 nM TNF-α for 24 hr decreased 
glycerol rate significantly (Porter et al., 2002). Low sensitivity to TNF-α also may 
explain adipose tissue response. TNF-α gene expression (Karcher et al., 2008) and its 
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concentrations in plasma (Rontved et al., 2005; Winkelman et al., 2007) of dairy cows 
increases significantly one week before calving and drops at calving day. Then, TNF-
α expression and its concentration in plasma increase again in the first two weeks 
after calving. Although not measured, the probability of high TNF-α concentrations 
desensitizing adipose tissue to TNF-α may not be ruled out. This observation could 
be supported by previous reports of increased endogenous expression of TNF-α in 
adipose tissue (Hube and Hauner, 1999). Glucagon ineffectiveness to affect adipose 
tissue glycerol release rates is consistent with previous reports indicating no effect of 
glucagon on in vitro measured glycerol rates in bovine adipose tissues (Etherton et al., 
1977). Other studies observed that glucagon decreased in vitro glycerol rates of 
caprine adipose tissues but only at high concentrations (~300 nM) (Bartos et al., 
1975).  
 To measure effect of subcutaneous glucagon injections and acute effects of 
TNF-α and glucagon on adipose tissue lipogenesis, rates of acetic acid incorporation 
in fatty acids were determined by in vitro experiments. Lipogenesis rates are in 
agreement with those of previous studies reports (Whitehurst et al.,1978; McNamara 
and Hillers, 1986a; McNamara and Hillers, 1986b; McNamara, 1989; McNamara et 
al., 1995; Lake et al., 2006). Other studies, however, reported almost 10 fold higher 
lipogenesis rates (Whitehurst et al., 1981; Mills et al., 1986; McNamara and Valdez, 
2005). The tendency of lipogenesis rates to decrease in the post-parturition stage in all 
cow groups agrees with other several studies showing that lipogenesis rates 
significantly decrease in the post parturition period (Mills et al., 1986; McNamara and 
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Hillers, 1986a; McNamara and Hillers, 1986b; McNamara et al., 1995; McNamara 
and Valdez, 2005). Esterification (Rukkwamsuk et al., 1999) and lipogeneic enzymes 
activities in liver (Murondoti et al., 2004) also decrease in the post-parturition period. 
Decreased lipogenesis rates in control and treatment cows can be explained by the 
low insulin plasma concentrations in the early post-parturition stage (Osman et al., 
2010). Insulin activates the key enzymes of fatty acid synthesis (Kresten, 2001). Low 
insulin concentration after calving may results in less gene expression of ACC and 
FAS. The pronounced tendency of lipogenesis rates to decrease after calving in 
glucagon-treated cows can be explained inhibition of ACC by glucagon (Holland et 
al., 1985; Yin et al., 2000).  
 Glycerol treatment significantly decreased lipogenesis rates. The mechanism 
of glycerol action on lipogenesis remains unclear. Acetate is produced as a result of 
glycerol ruminal fermentation (DeFrain et al., 2004). In the presence of rumen-
originated acetate, acetyl-CoA and palmitoyl-CoA intermediates will accumulate in 
adipose tissue because of the activity of acetyl-CoA synthetase, the enzyme 
responsible for acetyl-CoA synthesis from acetate in ruminant adipose tissue (Hanson 
and Ballard, 1967). The inhibitory effect of palmitoyl-CoA on ACC may explain the 
negative impact of glycerol on lipogenesis rates. Neither parturition nor cow 
treatment affected acetic acid oxidation to CO2 , however, ratio of acetic acid 
oxidation to CO2 to lipogenesis rate significantly increased after calving for cows 
treated with glucagon alone. This ratio increase is consistent with glucagon inhibition 
of ACC. Glucagon inhibits ACC but does not inhibit acetyl-CoA incorporation in 
TCA cycle. Subcutaneously injected glucagon and orally administered glycerol may 
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have an inhibitory action on lipogenesis that results in lower NEFA synthesis and 
ultimately lower TAG accumulation in the livers of cows susceptible to FLS.    
 Despite the reported inhibitory effect of TNF-α on lipogenesis (Cawthorn and 
Sethi, 2008), incubation of adipose tissues obtained from control and treatment cows 
for 2 hr with 1 nM TNF-α did not affect lipogenesis rates. In their study, Doerrler et 
al. (1994) reported that TNF-α required 16 hr incubation to inhibit ACC and FAS 
activity and expression in 3T3-L1 and 3T3-F442A adipocyte cell lines. In another 
study, ACC activity decreased significantly in cells from 30A-5 preadipocyte cell line 
after a 72 hr exposure to TNF-α (Pape and Kim, 1988).  Short incubation time (2 hr) 
can explain lack of response in our study. Low sensitivity because of elevated TNF-α 
concentration in plasma around parturition (Rontved et al., 2005; Winkelman et al., 
2007) also may explain lack of response in adipose tissue. In agreement with previous 
studies, adipose tissue incubation with 100 nM glucagon for 2 hr did not affect 
lipogenesis rates (Holland et al., 1985).  
Conclusion 
 This is the first study to measure the effect of subcutaneous glucagon 
injections used to treat FLS symptoms on the rates gluconeogenesis, lipolysis, and 
lipogenesis. Greater conversion rates of propionic acid to glucose than those observed 
for alanine. Epinephrine stimulated glycerol release rates for all cow and sample 
treatments. Lipogenesis rates significantly dropped in the post-calving period. The 
results presented in the current study suggest that the alleviating effect of 
subcutaneous glucagon injection on some FLS symptoms is not achieved by a direct 
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action on rates of gluconeogenesis in liver or lipolysis rates in adipose tissue but 
probably rather by long-term effects. Glucagon and glycerol inhibitory may inhibit 
lipogenesis rates and decrease NEFA and TAG synthesis and accumulation in the liver 
of dairy cows. Short incubation times and less absorption of in vitro regulators by 
tissue biopsies could have weakened the direct effects of glucagon and TNF-α on 
liver and adipose tissue. Therefore, longer incubation times with monolayer 
hepatocytes and adipocytes could be more effective to test the effect of cow treatment 
with glucagon subcutaneous injections on the rates of gluconeogenesis and lipolysis 
and lipogenesis in different tissues. 
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CHAPTER 3: GENERAL CONCLUSION 
General Discussion 
 Different studies emphasized the effect of subcutaneous injections of glucagon 
for 14 days after calving on different metabolic processes in both normal cows and 
cows with fatty liver. The objective of the present study is to measure the effect of 
subcutaneously administered glucagon for 14 days, starting at day 2 after calving, to 
dairy cows highly susceptible to fatty liver development on the rates of different 
metabolic pathways, specifically, gluconeogenesis, lipolysis, and lipogenesis, under 
the effect of different hormonal and substrate treatments. The hypothesis of this study 
is that subcutaneous injection of glucagon directly affects the turnover rates of 
gluconeogenesis in liver and the rates of lipolysis and lipogenesis in adipose tissue. 
Appropriate changes in these metabolic rates may result in relieving FLS symptoms. 
This study was designed to measure the rates of the three metabolic pathways before 
and after in vivo glucagon treatment and under different in vitro substrate and 
hormonal treatments such as TNF-α and epinephrine. 
 Liver tissues incubated with propionic acid produced significantly more 
glucose than did those incubated with alanine. This observation agrees with previous 
reports. In agreement with other studies, the ratios of propionic acid oxidation to CO2 
to glucose synthesis rates are much smaller that those of alanine. Gluconeogenesis 
rates measured were not affected by in vivo glucagon injections. Livers obtained from 
control and glycerol-treated cow utilized propionic acid at greater rates than did those 
from cows who received glucagon and glucagon plus glycerol treatments. Individual 
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cow variations and the low number of cows per treatment group make final 
conclusions about the effect of glucagon injections on the rates of substrates 
conversion to glucose difficult to draw. Nevertheless, the possibility of 
gluconeogenesis inhibition by elevated insulin concentrations right after glucagon 
injections into cows can explain the lower glucose synthesis rates in glucagon and 
glucagon plus glycerol treatment cows compared with those cows of the other two 
groups. Incubating liver tissues with TNF-α or glucagon did not affect glucose 
synthesis rates when propionic acid or alanine was used as precursor. TNF-α and 
glucagon did not affect propionic acid or alanine oxidation too. Impaired signal 
transduction of hepatocytes because of isolation procedure, low absorption of 
glucagon and TNF-α by liver tissues, and short incubation times are all probable 
explanations for the lack of effect of glucagon and TNF-α on gluconeogenesis rates. 
 Glycerol release rates reported in the current study are relatively lower than 
some previous reports. Feeding cows with high energy diets during dry period is 
usually accompanied by relatively high insulin plasma. Insulin inhibits lipolysis by 
decreasing cAMP cellular concentrations by either inhibiting adenylyl cyclase or 
activating phosphodiesterase or both. Insulin can also inhibit lipolysis by activating 
protein phosphatases and, in turn, decreasing active HSL concentrations. Relatively 
high insulin concentrations because of high energy feeding can explain the attenuated 
glycerol release rates in response to adipose tissue treatment with epinephrine. When 
stimulated by epinephrine, lipolysis rates tended to decrease in the post-calving stage 
in saline, glycerol- and glucagon plus glycerol-treated cows. Lower glycerol release 
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rates in postpartal versus prepartal stage can be attributed to the low responsiveness 
of adipose tissue to epinephrine in late pregnancy and early postpartum. It also can be 
explained by lipolysis inhibition by the usually elevated BHBA concentrations in 
plasma in the first pospartal week. Glucagon antagonism of BHBA inhibitory can 
explain less affected lipolysis rates in adipose tissues obtained from cows treated with 
glucagon only. Short incubation times may explain the neutral effects of TNF-α and 
glucagon on glycerol release rates. 
 The tendency of lipogenesis rates to decrease in the post-parturition stage in 
all cow groups agrees with results of other studies. Low insulin concentration after 
calving may result in decreased lipogenesis rates in control treatment. The 
pronounced tendency of lipogenesis rates to decrease after calving in glucagon-
treated cows can be explained by glucagon inhibition of ACC. In vivo glycerol 
treatment significantly decreased lipogenesis rates. The mechanism of inhibitory 
effect of glycerol on lipogenesis is not clear. Accumulating palmitoyl-CoA, 
synthesized from excess acetate, inhibits ACC. The ratio of acetic acid oxidation to 
lipogenesis rate significantly increased after calving for cows treated with glucagon 
alone. This result is consistent with glucagon inhibition of ACC but not acetyl-CoA 
incorporation in TCA cycle. Subcutaneously injected glucagon and orally 
administered glycerol may have an inhibitory action on lipogenesis that results in 
lower NEFA synthesis and ultimately lower TAG accumulation in the livers cows 
susceptible to FLS.    
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Recommendation for Future Research 
 This study shed light on the direct effects of subcutaneous injections of 
glucagon on three major metabolic pathways, i.e. gluconeogenesis in liver tissues and 
lipolysis and lipogenesis in adipose tissues during the course of FLS development 
during the periparturient period of dairy cattle. The current study conducted a 
comparison between the rates of these metabolic pathways in the late prepartal and 
early postpartal stages in cows with relatively moderate fatty liver cases.  Previous 
studies conducted in this research group using the dietary supplementation of 1,3-
butanediol were more effective in inducing FLS in transition cow. Inducing FLS with 
this compound and then measuring the rates of different metabolic pathways could 
give a clearer and more definitive answer about the severity of the disease.   
 The effect of subcutaneous injections of glucagon on the expression of 
different genes is another aspect that could be investigated in future research. 
Expression of genes of key gluconeogenic enzymes and lipid metabolic enzymes in 
addition to expressions of genes of major metabolic hormones such as glucagon and 
insulin also could be investigated under normal and fatty liver conditions. Measuring 
gene expression of these enzymes and hormones under normal and fatty liver 
conditions at different times after parturition could give a clear answer about the 
differences between short-term and long-term changes during the development of the 
disease.  
 More studies need to be done to investigate tissue incubations under different 
conditions. Further studies using monolayer hepatocytes or adipocytes drawn from 
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liver and adipose tissues obtained from different treatment cows can be more useful 
than directly using the original biopsied tissues. In these cell culture studies, tissue 
quantity and regulatory factor availability to all cells are not a limiting factor. With 
this factor being avoided, then, incubation times, incubations conditions, and effective 
factor concentrations are optimized more easily.  
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